Was ist die Webseite?

Prurigo Nodularis League

Startseite
Deutschland
Münster
Prurigo Nodularis League

Despite its prevalence and severity, prurigo nodularis remains a relatively unknown skin disease. Prurigo nodularis ist eine relativ unerforschte Erkrankung.

Our goal is to raise global awareness and provide current news relating to this debilitating illness. Hier finden Sie aktuelle News rund um das Netzwerk Prurigo nodularis Liga.

05/04/2026

Happy Easter from the Prurigo Nodularis League 🐰💙

Wishing you a wonderful time with your family and friends, filled with joy, love, and good health! 🌸

27/03/2026

Treatment of Chronic Prurigo

👉 What treatment options are available?
We provide a patient-friendly overview based on current guidelines. 💙

From topical therapies to modern biologics like dupilumab and nemolizumab, treatment is highly individualized.

💙 Important
Managing chronic prurigo often requires a combination of different approaches.

What treatments have helped you? Share your experience below 👇

25/03/2026

💙𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗣𝗿𝘂𝗿𝗶𝗴𝗼

👉 What treatment options are available?
We provide a patient-friendly overview based on current guidelines. 💙

From topical therapies to modern biologics like dupilumab and nemolizumab, treatment is highly individualized.

💙 𝗜𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁
Managing chronic prurigo often requires a combination of different approaches.

What treatments have helped you? Share your experience below 👇

13/03/2026

𝗙𝗢𝗕𝗜 𝟮𝟬𝟮𝟲 🌟
𝟯𝟬𝘁𝗵 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗧𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗪𝗲𝗲𝗸 𝗶𝗻 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗮𝗹 𝗗𝗲𝗿𝗺𝗮𝘁𝗼𝗹𝗼𝗴𝘆 & 𝗩𝗲𝗻𝗲𝗿𝗲𝗼𝗹𝗼𝗴𝘆

📅 𝟬𝟲–𝟭𝟬 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟲 | 𝗠𝘂𝗻𝗶𝗰𝗵, 𝗚𝗲𝗿𝗺𝗮𝗻𝘆

Our experts from the 𝗖𝗼𝗺𝗽𝗲𝘁𝗲𝗻𝗰𝗲 𝗳𝗼𝗿 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗣𝗿𝘂𝗿𝗶𝘁𝘂𝘀 𝗖𝗲𝗻𝘁𝗲𝗿 𝗮𝘁 𝘁𝗵𝗲 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗠ü𝗻𝘀𝘁𝗲𝗿 will be presenting lectures on pruritus and prurigo:

👩‍⚕️ 𝗦𝗼𝗻𝗷𝗮 𝗦𝘁ä𝗻𝗱𝗲𝗿
👩‍⚕️ 𝗖𝗹𝗮𝘂𝗱𝗶𝗮 𝗭𝗲𝗶𝗱𝗹𝗲𝗿

💡 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆: Hands-on course on practical disease management & modern therapy options for pruritus.

💡 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆 & 𝗙𝗿𝗶𝗱𝗮𝘆: Further lectures on pathophysiology, current guidelines, and therapy options for pruritus and prurigo. (Check the next slide for the full program!)

We look forward to your participation and an inspiring professional exchange! 🤝✨

12/03/2026

Prurigo nodularis (PN) typically affects the extensor surfaces of the arms, legs, and trunk—areas prone to repeated scratching.

The palms, however, are a rare site. Their thick stratum corneum, absence of hair follicles, and distinct neural and immune microenvironment usually protect them from developing classic PN nodules. As a result, palmar PN is frequently overlooked or misdiagnosed, most commonly as palmoplantar pustulosis or viral warts.

In this remarkable case, a 58-year-old woman suffered from 15 years of severe palmar pruritus and nodules, significantly impairing hand function and quality of life. Persistent scratching eventually led to disease spread beyond the palms.

Only through careful clinical evaluation, histopathology, and immunological assessment was the correct diagnosis established:
Prurigo nodularis with predominant palmar involvement—a presentation rarely reported in the literature.

Targeted therapy with high-potency topical corticosteroids under occlusion, combined with antihistamines, successfully interrupted the itch–scratch cycle, resulting in rapid improvement and sustained remission.

📍 Miyamoto et al.
🗓️ Indian Journal of Dermatology, Venereology and Leprology, Epub November 2025

✨ Take-home message: When chronic itch persists in an unexpected location, thinking beyond typical patterns can be life-changing for patients.

05/03/2026

𝗡𝗲𝗺𝗼𝗹𝗶𝘇𝘂𝗺𝗮𝗯 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗦𝗸𝗶𝗻 𝗠𝗶𝗸𝗿𝗼𝗯𝗶𝗼𝗺𝗲 𝗶𝗻 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗣𝗿𝘂𝗿𝗶𝗴𝗼

In a recent study, Zhou et al. 2026 investigated the influence of nemolizumab treatment on the skin microbiome. They confirmed the dominance of a special bacterium, calles Staphylococcus aureus, in the lesional skin of prurigo nodularis patients 🦠.

Furthermore, they were able to show that nemolizumab leads to a normalization of the microbiome, specifically the composition of the microbiome. This demonstrates the importance of microbiome studies and the interconnectedness of various parameters in skin homeostasis.

Full text can be found: https://pubmed.ncbi.nlm.nih.gov/40571154/

24/02/2026

Chronic prurigo affects more than just the skin 💙

Trigger awareness, stress management, social support, and healthy daily routines can make a real difference 🌿

In this post, we share practical tips of our patients for you to to help you support your overall well-being.

You’re not alone 🤍

10/02/2026

𝑬𝒙𝒄𝒊𝒕𝒊𝒏𝒈 𝑨𝒏𝒏𝒐𝒖𝒏𝒄𝒆𝒎𝒆𝒏𝒕!

We are delighted to announce that Dr. Sonja Ständer will once again be speaking at the 𝐀𝐀𝐃 𝐀𝐧𝐧𝐮𝐚𝐥 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 𝟐𝟎𝟐𝟔, taking place in Denver, March 27–31, 2026!
As an internationally recognized expert in dermatology, she will present her talk
“When stress gets under your skin” on March 30,
highlighting how stress impacts the skin and exploring emerging therapeutic approaches.
Don’t miss this opportunity to gain valuable insights at the intersection of stress, skin, and innovative treatment strategies!

30/01/2026

🩺 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝗻𝗴 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗣𝗿𝘂𝗿𝗶𝗴𝗼

Chronic prurigo is mainly a clinical diagnosis, based on the typical appearance of persistent, itchy nodules. A thorough skin examination is key, and skin biopsy may be considered in unclear cases. Assessment of itch severity and impact on daily life can guide treatment.

24/01/2026

𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗣𝗿𝘂𝗿𝗶𝗴𝗼 𝗮𝗳𝗳𝗲𝗰𝘁𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗷𝘂𝘀𝘁 𝘁𝗵𝗲 𝘀𝗸𝗶𝗻 – 𝗶𝘁 𝗶𝗺𝗽𝗮𝗰𝘁𝘀 𝘆𝗼𝘂𝗿 𝗯𝗼𝗱𝘆, 𝗺𝗶𝗻𝗱, 𝗮𝗻𝗱 𝗱𝗮𝗶𝗹𝘆 𝗹𝗶𝗳𝗲. 😔💙

What challenges do you face living with this skin condition? Tell us your story.
�

17/01/2026

𝗦𝘆𝗺𝗽𝘁𝗼𝗺𝘀 𝗼𝗳 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗣𝗿𝘂𝗿𝗶𝗴𝗼

Typical symptoms of chronic prurigo include persistent pruriginous symptoms and intensely pruriginous skin lesions.

👉 Important to know: you are not alone — chronic prurigo is a medical condition.

09/01/2026

𝗣𝗿𝘂𝗿𝗶𝘁𝘂𝘀-𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝗦𝘁𝗿𝗲𝘀𝘀 𝗦𝗰𝗮𝗹𝗲 (𝗣𝗔𝗦𝗦)

Chronic itch is more than a skin symptom — it can be stressful, exhausting, and emotionally draining. 😣💭

📊 In a recent pilot study, 𝟵𝟰.𝟱% 𝗼𝗳 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 𝗰𝗵𝗿𝗼𝗻𝗶𝗰 𝗽𝗿𝘂𝗿𝗶𝘁𝘂𝘀 reported that their itch caused 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗱𝗶𝘀𝘁𝗿𝗲𝘀𝘀 within the last two weeks.

That’s why researchers developed the 𝗣𝗿𝘂𝗿𝗶𝘁𝘂𝘀-𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲𝗱 𝗦𝘁𝗿𝗲𝘀𝘀 𝗦𝗰𝗮𝗹𝗲 (𝗣𝗔𝗦𝗦)— a questionnaire designed specifically to assess 𝗶𝘁𝗰𝗵-𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝗱𝗶𝘀𝘁𝗿𝗲𝘀𝘀 📝.

PASS focuses on feelings such as nervousness, tension, mental exhaustion, fatigue, and the urge to scratch more when feeling distressed.

This matters because 𝗴𝗲𝗻𝗲𝗿𝗮𝗹 𝘀𝘁𝗿𝗲𝘀𝘀 𝗾𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝗻𝗮𝗶𝗿𝗲𝘀 𝗼𝗳𝘁𝗲𝗻 𝗳𝗮𝗶𝗹 𝘁𝗼 𝗰𝗮𝗽𝘁𝘂𝗿𝗲 𝘄𝗵𝗮𝘁 𝗺𝗮𝗸𝗲𝘀 𝗶𝘁𝗰𝗵-𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝗱𝗶𝘀𝘁𝗿𝗲𝘀𝘀 𝘂𝗻𝗶𝗾𝘂𝗲.

With PASS, clinicians can better recognize the hidden burden of chronic itch and identify when distress is contributing to worsening symptoms.

It also allows treatment success to be measured not only by “less itch”, but by “less distress caused by itch.”

🔗 𝗥𝗲𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗰𝗮𝗻 𝗯𝗲 𝗳𝗼𝘂𝗻𝗱 𝗵𝗲𝗿𝗲:
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1683259/full

Adresse

Münster

Webseite

http://www.skinhealthcampus.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Prurigo Nodularis League erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.